Mercury (Blood)

Hormone/ Element

Report in 12Hrs

At Home

No Fasting Required

Details

Measures mercury exposure.

₹2,309₹3,298

30% OFF

Mercury (Blood) - Comprehensive Test Information Guide

Why is it done?
- Measures total mercury concentration in blood to detect toxic exposure and assess potential mercury poisoning or contamination from occupational, environmental, or dietary sources
- Evaluates exposure in individuals with suspected acute or chronic mercury intoxication presenting with neurological, renal, or gastrointestinal symptoms
- Monitors occupational exposure in workers in dental, mining, chemical, or manufacturing industries with mercury handling responsibilities
- Assesses exposure from dietary sources, particularly high mercury fish consumption (swordfish, shark, king mackerel) or contaminated foods
- Evaluates environmental contamination from industrial accidents, spills, or proximity to mercury sources
- Investigates sources in patients with unexplained tremors, cognitive decline, mood disturbances, or nephrotic syndrome
- Monitors patients after chelation therapy initiation for mercury toxicity to assess treatment efficacy
Normal Range
- Reference Range: Less than 5-10 µg/L (micrograms per liter) or less than 5-10 ng/mL (nanograms per milliliter) is generally considered normal in unexposed individuals
- Occupational Exposure Threshold: Up to 15 µg/L may be acceptable for occupationally exposed workers with adequate safety measures
- Borderline Elevated: 10-20 µg/L suggests mild exposure; investigation of source recommended
- Elevated: 20-50 µg/L indicates significant exposure requiring medical evaluation and source removal
- High/Toxic: Greater than 50 µg/L suggests acute or severe chronic toxicity requiring urgent medical intervention and possible chelation therapy
- Units of Measurement: µg/L (micrograms per liter), ng/mL (nanograms per milliliter), or ppt (parts per trillion)
- Interpretation Note: Normal ranges may vary between laboratories; reference lab values should be used for interpretation. Results must be correlated with clinical presentation and exposure history
Interpretation
- Normal Results (<5-10 µg/L): No clinically significant mercury exposure detected; minimal health risk from mercury
- Mild Elevation (10-20 µg/L): Suggests exposure from dietary sources (fish consumption) or minimal environmental contamination; may indicate early occupational exposure; clinical assessment and source identification recommended
- Moderate Elevation (20-50 µg/L): Indicates significant cumulative exposure or recent acute exposure; manifested by symptoms such as tremor, cognitive dysfunction, or autonomic instability; requires source removal and medical monitoring; possible chelation therapy consideration
- High/Toxic Levels (>50 µg/L): Acute or severe chronic poisoning; may present with severe neurological symptoms, renal dysfunction, gastrointestinal distress, and psychological effects; requires urgent medical intervention, immediate source removal, and aggressive chelation therapy initiation
- Factors Affecting Results:
  - Recent fish or seafood consumption (increases levels within 24-48 hours)
  - Type of mercury exposure (methylmercury vs inorganic mercury have different toxicity profiles)
  - Duration of exposure (acute vs chronic with different symptom presentations)
  - Individual metabolic variability and renal function affecting mercury elimination
  - Age and pregnancy status (pregnant women and children show greater toxicity risk)
  - Nutritional status (selenium and antioxidant levels may modulate mercury toxicity)
- Clinical Significance: Blood mercury testing reflects recent exposure over past weeks; does not assess total body mercury burden or tissue accumulation; hair and urine mercury may provide complementary information for chronic exposure assessment
Associated Organs
- Primary Organ Systems Affected:
  - Central Nervous System: Primary target organ; causes tremor (mercurialism), cognitive dysfunction, memory impairment, personality changes, anxiety, depression, and emotional lability (erethism mercurialis)
  - Peripheral Nervous System: Causes sensory neuropathy, paresthesias, visual field constriction, and auditory symptoms; methylmercury particularly affects sensory nerves
  - Kidneys: Causes proteinuria, nephrotic syndrome, glomerulonephritis, and progressive renal dysfunction through immune-mediated mechanisms
  - Gastrointestinal Tract: Causes gingivitis, salivation, abdominal cramps, diarrhea, and inflammatory bowel symptoms; may lead to blue-black gum discoloration
  - Reproductive System: Affects fertility and may cause teratogenic effects in fetal development; particularly methylmercury crosses placental barrier affecting fetal neurodevelopment
  - Immune System: Activates autoimmune responses leading to nephrotic syndrome and other immune-mediated conditions
- Associated Medical Conditions:
  - Minamata disease: Severe neurological condition from methylmercury exposure causing ataxia, tremor, cognitive deterioration
  - Hunter-Russell syndrome: Sensory paresthesias, constricted visual fields, hearing loss from mercury exposure
  - Mercurial nephrotic syndrome: Autoimmune kidney disease secondary to mercury exposure
  - Erethism mercurialis: Psychophysiological syndrome with emotional lability, anxiety, social withdrawal, and personality changes
  - Congenital Minamata disease: Developmental neurotoxicity, intellectual disability, cerebral palsy from in-utero exposure
- Potential Complications from Abnormal Results:
  - Irreversible neurological damage if chronic exposure continues without intervention
  - Progressive renal failure and need for dialysis from nephrotic syndrome
  - Cardiovascular complications including hypertension and arrhythmias
  - Severe visual impairment and auditory loss from peripheral nervous system damage
  - Reproductive and developmental effects including infertility and birth defects
Follow-up Tests
- Initial Follow-up Tests for Elevated Results:
  - Hair mercury testing: Assesses chronic exposure; correlates with neurological symptoms and reflects exposure over 6-12 weeks
  - Urine mercury testing: Evaluates renal excretion capacity and may indicate inorganic mercury exposure; useful baseline for chelation therapy monitoring
  - Comprehensive metabolic panel: Assess kidney function (BUN, creatinine), liver function, and electrolyte abnormalities
  - Urinalysis with microscopy: Screen for proteinuria, hematuria, and nephrotic syndrome development
  - 24-hour urine protein: Quantify proteinuria to assess degree of renal involvement
- Neurological Assessment Tests:
  - Nerve conduction studies and EMG: Detect peripheral neuropathy and quantify neuromuscular involvement
  - Cognitive and neuropsychological testing: Assess tremor, memory, attention, mood disturbances, and psychological effects
  - Brain MRI: Rule out structural abnormalities and assess for central nervous system mercury deposition
  - Ophthalmology evaluation: Assess for visual field constriction and visual acuity changes
  - Audiometry: Evaluate hearing loss and auditory nerve involvement
- Immunological Testing:
  - Kidney antibodies and complement levels: Assess autoimmune glomerulonephritis development
  - Serum immunoglobulins: Evaluate immune dysfunction and autoimmune response activation
- Monitoring During Chelation Therapy:
  - Serial blood mercury levels: Baseline, periodic testing during treatment, and post-treatment to confirm effectiveness and monitor for rebound
  - 24-hour urine mercury (post-chelation): Increased mercury excretion indicates mobilization of tissue mercury stores
  - Complete blood count: Monitor for chelation agent side effects and bone marrow suppression
  - Liver function tests: Monitor hepatotoxicity during chelation therapy
- Monitoring Frequency:
  - Acute exposure/toxicity: Weekly blood mercury testing until levels normalize and symptoms resolve
  - Occupational exposure: Quarterly to annual monitoring if exposure continues; more frequent if levels are trending upward
  - After source removal: Repeat testing at 4-6 weeks and 3 months to document clearance and recovery
Fasting Required?
- Fasting Requirement: No - Fasting is NOT required for blood mercury testing
- Patient Preparation Instructions:
  - No dietary restrictions: Patients may eat and drink normally before the test
  - However: If recent high fish consumption, provide this information to the healthcare provider as it may affect interpretation
  - Continue regular medications: No need to hold routine medications before testing
  - Minimize contamination: Ensure hands and forearm are clean; avoid mercury-containing products (some thermometers, barometers) before testing
  - Report exposures: Inform phlebotomist and physician about occupational mercury exposure, dental amalgam fillings, recent fish consumption, and any medications
  - Timing considerations: For suspected acute exposure, test as soon as possible; for baseline occupational screening, any time is appropriate
- Special Considerations:
  - Avoid topical mercury products: Do not use mercurochrome or other mercury-based medications before testing
  - Collection tube specifications: Blood must be drawn into special heavy metal-free tubes (usually gray-top or specific collection tubes designated for mercury testing)
  - Proper handling: Sample must be stored and transported properly to prevent contamination or hemolysis
  - Dental considerations: Inform physician if extensive dental work with mercury amalgam fillings; this may slightly elevate results
  - Pregnancy considerations: Pregnant women should inform their provider; fetal susceptibility to mercury is significantly higher

How our test process works!